Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality | Journal of the American Chemical Society
![Tau Phosphorylation Sites Work in Concert to Promote Neurotoxicity In Vivo | Molecular Biology of the Cell Tau Phosphorylation Sites Work in Concert to Promote Neurotoxicity In Vivo | Molecular Biology of the Cell](https://www.molbiolcell.org/cms/10.1091/mbc.e07-04-0327/asset/images/medium/zmk0120783400001.jpeg)
Tau Phosphorylation Sites Work in Concert to Promote Neurotoxicity In Vivo | Molecular Biology of the Cell
![Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases | Nature Reviews Drug Discovery Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd2111/MediaObjects/41573_2007_Article_BFnrd2111_Fig1_HTML.jpg)
Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases | Nature Reviews Drug Discovery
![Phosphorylation of Tau Protein Associated as a Protective Mechanism in the Presence of Toxic, C-Terminally Truncated Tau in Alzheimer's Disease | IntechOpen Phosphorylation of Tau Protein Associated as a Protective Mechanism in the Presence of Toxic, C-Terminally Truncated Tau in Alzheimer's Disease | IntechOpen](https://cdnintech.com/media/chapter/43045/1512345123/media/image5.jpeg)
Phosphorylation of Tau Protein Associated as a Protective Mechanism in the Presence of Toxic, C-Terminally Truncated Tau in Alzheimer's Disease | IntechOpen
![Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies - ScienceDirect Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0925443921000958-gr1.jpg)
Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies - ScienceDirect
![Don't Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies | Molecular Neurodegeneration | Full Text Don't Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies | Molecular Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13024-021-00460-5/MediaObjects/13024_2021_460_Fig1_HTML.png)
Don't Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies | Molecular Neurodegeneration | Full Text
![Advances in the Pathogenesis of Alzheimer's Disease: Focusing on Tau-Mediated Neurodegeneration | Translational Neurodegeneration | Full Text Advances in the Pathogenesis of Alzheimer's Disease: Focusing on Tau-Mediated Neurodegeneration | Translational Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2047-9158-1-24/MediaObjects/40035_2012_Article_28_Fig1_HTML.jpg)
Advances in the Pathogenesis of Alzheimer's Disease: Focusing on Tau-Mediated Neurodegeneration | Translational Neurodegeneration | Full Text
![Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease | PNAS Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease | PNAS](https://www.pnas.org/cms/10.1073/pnas.1916895117/asset/4ff9d9d6-8add-49b9-a1fa-9f4536c480f0/assets/graphic/pnas.1916895117fig01.jpeg)
Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease | PNAS
![Alzheimer's disease: Ablating single master site abolishes tau hyperphosphorylation | Science Advances Alzheimer's disease: Ablating single master site abolishes tau hyperphosphorylation | Science Advances](https://www.science.org/cms/10.1126/sciadv.abl8809/asset/115ce3ce-563f-4c53-b26b-500dada18244/assets/images/large/sciadv.abl8809-f2.jpg)
Alzheimer's disease: Ablating single master site abolishes tau hyperphosphorylation | Science Advances
![Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn‐mediated local protein translation | The EMBO Journal Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn‐mediated local protein translation | The EMBO Journal](https://www.embopress.org/cms/asset/fed21c09-5c29-4ea5-95d4-c64fc2344272/embj201797724-abs-0001-m.jpg)
Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn‐mediated local protein translation | The EMBO Journal
![Site‐Specific Hyperphosphorylation Inhibits, Rather than Promotes, Tau Fibrillization, Seeding Capacity, and Its Microtubule Binding - Haj‐Yahya - 2020 - Angewandte Chemie International Edition - Wiley Online Library Site‐Specific Hyperphosphorylation Inhibits, Rather than Promotes, Tau Fibrillization, Seeding Capacity, and Its Microtubule Binding - Haj‐Yahya - 2020 - Angewandte Chemie International Edition - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3ccfaf80-1ee8-42ae-9282-928100318413/anie201913001-fig-0006-m.jpg)